Kura Oncology, Inc.

Kura Oncology, Inc.verified

KURA

Price:

$8.94

Market Cap:

$695.21M

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase that is in Phase II clinical trials for the treatment of solid tumors and hematologic indications. The company has a ...[Read more]

Industry

Biotechnology

IPO Date

2015-09-16

Stock Exchange

NASDAQ

Ticker

KURA

The Dividend Yield as of December 2024 (TTM) for Kura Oncology, Inc. (KURA) is 0%

According to Kura Oncology, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Kura Oncology, Inc. (KURA) Historical Dividend Yield (quarterly & annually)

How has KURA Dividend Yield performed in the past?

The mean historical Dividend Yield of Kura Oncology, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), KURA's Dividend Yield was at its highest in in the December 2014 quarter at 0%. The Dividend Yield was at its lowest in in the December 2014 quarter at 0%.

Quarterly (TTM)
Annual

Average

0%

Median

0%

Minimum

0%

Maximum

0%

Kura Oncology, Inc. (KURA) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Kura Oncology, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Dividend Yield = 0%

Minimum Annual Increase = 0%

Minimum Annual Dividend Yield = 0%

Quarterly (TTM)
Annual
YearDividend YieldChange
20230%0%
20220%0%
20210%0%
20200%0%
20190%0%
20180%0%
20170%0%
20160%0%
20150%0%
20140%0%

Kura Oncology, Inc. (KURA) Average Dividend Yield

How has KURA Dividend Yield performed in the past?

The current Dividend Yield of Kura Oncology, Inc. (KURA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

0%

5-year avg

0%

10-year avg

0%

Kura Oncology, Inc. (KURA) Dividend Yield vs. Peers

How is KURA’s Dividend Yield compared to its peers?

Kura Oncology, Inc.’s Dividend Yield is less than Protagonist Therapeutics, Inc. (0%), less than Merus N.V. (0%), less than Replimune Group, Inc. (0%), less than Cerevel Therapeutics Holdings, Inc. (0%), less than KalVista Pharmaceuticals, Inc. (0%), less than Crinetics Pharmaceuticals, Inc. (0%), less than Theseus Pharmaceuticals, Inc. (0%), less than Viridian Therapeutics, Inc. (0%), less than Gracell Biotechnologies Inc. (0%), less than Monte Rosa Therapeutics, Inc. (0%), less than Design Therapeutics, Inc. (0%), less than Erasca, Inc. (0%), less than Cogent Biosciences, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Kiniksa Pharmaceuticals, Ltd. (0%), less than Day One Biopharmaceuticals, Inc. (0%), less than Inozyme Pharma, Inc. (0%), less than Zentalis Pharmaceuticals, Inc. (0%), less than Syndax Pharmaceuticals, Inc. (0%),

Build a custom stock screener for Kura Oncology, Inc. (KURA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kura Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kura Oncology, Inc. (KURA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kura Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Dividend Yield?

How can you use the Dividend Yield?

What is Kura Oncology, Inc.'s Dividend Yield?

How is the Dividend Yield calculated for Kura Oncology, Inc. (KURA)?

What is the highest Dividend Yield for Kura Oncology, Inc. (KURA)?

What is the 3-year average Dividend Yield for Kura Oncology, Inc. (KURA)?

What is the 5-year average Dividend Yield for Kura Oncology, Inc. (KURA)?

How does the current Dividend Yield for Kura Oncology, Inc. (KURA) compare to its historical average?